{"name":"ImmuPharma","slug":"immupharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IPP-201101","genericName":"IPP-201101","slug":"ipp-201101","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"IPP-201101","genericName":"IPP-201101","slug":"ipp-201101","phase":"phase_3","mechanism":"IPP-201101 is an immunomodulatory compound designed to enhance immune responses against disease targets.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOaEhzcnQtXzg0TUUtTFZvd1ltS1N3cFJnNUhjeHNOeDllLThIcEY0UlNwdHlNa2hvSloxWHJGUkhFQ1lNeFNZaTVpYWFJWmVzTFhDekR4RVJTR0xMZmRhTUs4VERzajJ3cTFrWGY2LXZRcWUxbEVHSm9VaWl3eW9aRUNhM3F4REZ4Sy1VUHdpOF9SdEh0V0ZmUFBnaUZ5Y3dSZ1B0NHRHZzFUcTFjX09RSG5sZC1oSDJkYnpIRlYtbGdXV3dwWjJ5bVBIYVIxTFZEeWk3b3N2RllIdVBFZ25lQzJHa28yT0hQSldNUjBtdWVUbWxMbUxYS0ZVakxteWJ0?oc=5","date":"2026-03-27","type":"trial","source":"Proactive financial news","summary":"ImmuPharma advances P140 partnering talks as patent progress and new study data strengthen programme - Proactive financial news","headline":"ImmuPharma advances P140 partnering talks as patent progress and new study data strengthen programme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPemI4eGFzcWhhckM4XzhON3hwR1ZDVUlONFdhYmdEYmpiWU5vZ1BzRHJubk9KMVMxelBCRmt2T3Z0QjRqRUJkSW85STJXX2x4NWJnRjJCRDI1NEs5WEE1dzQ3SENyeXZQRi1td1Job25sSy01OEhTem1wXzBOV3RPWl95dTNMcWRJVmUwSGtqU1lmWEVseWVQNXo3UHNXdVNEa1h2RVI3WFEzamNCb051clVvcVR2djQ0UEczYTg2ZW05OFVlUHk4MmZmcXdBWlk?oc=5","date":"2026-03-27","type":"pipeline","source":"Proactive financial news","summary":"Streamlined ImmuPharma pushes ahead with drug research efforts - Proactive financial news","headline":"Streamlined ImmuPharma pushes ahead with drug research efforts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNUl8xaWtvaExhSmNnLUZsN0dqMjBfUnBrSU1WWWlueHRsbDNKY2hudmJKVWhCN1E0ci1aN2ozQXJmZXE1MVNRNmVpZW95bzR1VER5dTdFOHV2N2R1cXUtaXBSQkdXcE1PYUlkUnJiZl9hTHFCaHBGbzU4NTROSWlEZjVLaHZQSVBEei15NFJXczVTVkJfTzQ5d3ByeGU?oc=5","date":"2026-03-27","type":"trial","source":"Share Talk","summary":"ImmuPharma PLC advances P140 talks as new data strengthens programme - Share Talk","headline":"ImmuPharma PLC advances P140 talks as new data strengthens programme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQb01yR3RXOHJTY25mQ1NBR1g4OHRkbTFfME04RG5kYlZfTHhqRGgyUVdwNVdvSkR1VjkwSUVROG9OZEl6THc3MVdYUV8yXzBEWFd6LVlYQWYyVmc4dEJRN3pTVVBCRkFZX3NFdWVFQ2x2R1BnQ2N1Y2E3VFJoMGt3cU1lQ3R1cy1VRUhLMlRrOG5pQW1fS1E?oc=5","date":"2026-02-16","type":"pipeline","source":"The Armchair Trader","summary":"AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West - The Armchair Trader","headline":"AIM Market Roundup: Immupharma, Pebble Beach, Tungsten West","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPN0RzZTZOaVdaTmJnOUZkSVRQZmNOLWhzckdnTy1HaTJzZHFNa0pIcFlnTEZjRWxLbHc1RXk4RHgxN1Jjb3lXSFdKQnVxejdOak1aZ25IcEE4Z1dhMlFUb0JXZi1RblNLZ1JUR1FFdnVIV3BTdEdQenJ2Y250NWlLQndFSmFQakNRRmhZY1VzMmQtdDJwZGVkVUx2aVBDMVBLLVpPZVU4TjktVVREM0ZYT2g4NjItM3RVQW5pTFNJQ0d3WVNILWRZa0x1S0VKQ3lFOGZPR1RYRlpCZw?oc=5","date":"2025-11-28","type":"deal","source":"Research Tree","summary":"ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026 - Research Tree","headline":"ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPMU9vY1VHYWw3d2xod01RZ0h0TmdaTDVNVE9ZaWdXM2lfUkpfNFFGcURzZWF1RXJBMmZCMnZ1OFlkZHpyUklUc2xJeTk2WTNxV2FmVmlLOUxKdEl0YkFMQW5LaXpiVUF6X1dMblVJamNZeDd2WWRVRjZNNUtTUURqQkxDbHNWYkJGbG41bHktbmo3YjFHa3ZUWGE3QVQzZXF3Y0pGUFdBMXdRc3JiLThlVTh1UkZZb3BQQVYwdkJ1c0VGQ3lBeEV3T1pNeVJLZkdNZURvUm5Wa2VRbXdj?oc=5","date":"2025-11-24","type":"deal","source":"Proactive Investors","summary":"ImmuPharma draws interest from major pharma groups for P140 partnership - Proactive Investors","headline":"ImmuPharma draws interest from major pharma groups for P140 partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMl8zR0h6Y2htTXBKU0dDZ3VFcHlmMlpxaHg5dHJDd1RicS1LTVJjYjVKNlkxVzdYd2RpRUV4b3h2MGlYcXl1N0JUZ1NrTVJTS0c4emJaQWR2eWx2UzNTQzlzVjhkMzd5SDM0LXBsMXdZSEU1b0t1dUt0NURtU1hKYkZNTkRlUGZyeWc?oc=5","date":"2025-10-27","type":"regulatory","source":"London South East","summary":"Immupharma Regulatory News (IMM) - London South East","headline":"Immupharma Regulatory News (IMM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPVjZMZU1CWE9mWFd5VzJkajI5SXNFZzNfekthVVRULXN6Rnh6dnR0cTYzTG9yN2hlQVh3QnRKaldaQl8zNGlhLTRnc1NNalNCeFd4QkNZalZtdXRFX1IwYWt2b3cyOV82OHFlNEE5SWprbG1JNmkwRXdYdTNQWmE2M1Z1Mmw4OTNIMXR2eG51T0VVb2R0enBiWEhFcVhabkJhVDkwUUpzT004ZUdwbmpJdVBWZG5LUzRQWXpqWGZjeHVTbjYxczRMbExKdHlySnNydUNwbkxBMUlyYzY5clVlZg?oc=5","date":"2025-10-13","type":"pipeline","source":"Proactive financial news","summary":"ImmuPharma appoints veteran fund manager Ketan Patel as independent director | AIM:IMM - Proactive financial news","headline":"ImmuPharma appoints veteran fund manager Ketan Patel as independent director | AIM:IMM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQcEszbHJuYUZXaXZTakhUUU9TRmxRd2Q1dFd5bV8xTTNUNnkwMDVsVlcyaGFkbHg4QnlpTlc3Y0dVeWpZZElfbVVlMVBHb2FSd1BEVURIR1NoZW13TnVMMGJwZ2ZZUmpRWUlDbGF2MkM3X2VTRW5NNy1XYWdWWGgwa3FTOA?oc=5","date":"2025-09-16","type":"pipeline","source":"Yahoo Finance","summary":"With 80% ownership in ImmuPharma plc (LON:IMM), institutional investors have a lot riding on the business - Yahoo Finance","headline":"With 80% ownership in ImmuPharma plc (LON:IMM), institutional investors have a lot riding on the business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQRGRHTk9jR0Jjb1RNMlpYWnBUMzNRNmQxZVlQdzNiWTFoclFaaHVucThSUml1TlluMjVGTlZOOTlGNGpWU21xQjQwR1FOSHd6NWt5Vm9icFdjWnhwR0xiWnNDckZucmU4TkRZWmdxay1JTXdlREJTLUJrZXgxSEVvVGRObTlqWGdLa0JFdzJmMWhjeC1CS1BCLTVxdFJVdjRHV2JuUTBQVktiMEJVWHVfMmY3OUpXUHppMmxFZ1dLcExXN3pBSXZUSXdFd1dPVGV1T2ttRklTZDltYnpMcndRd9IB5gFBVV95cUxPUERKZnpHUFVjbjlxckZiZWhvdC1kS0RQSFUyTGxCazhBT0ZBcUc2a2lEVnhlWWZ1Y0Q0WmYwaHRfX0tsb0J5T1hmS2ItLXpwbVdFaGZRNmkwMFNuMkdoemdYeUJ5N2czeS1rUXFQZmtLN0ZrLTZCc3d5eXVpLTZQOHhIcW9mWlBLWm85c1dobDhUUEhNd0VxQUh6U0dUbk5oeWNRQU9BM2p2T2pwQlpLazVUMTdOR0R0RmtvUUtwY2NSNUhoWUpnaHpvd1piT3k0SmlfczN2RHRIU0NCWXc1RVdERkhiZw?oc=5","date":"2025-09-16","type":"pipeline","source":"simplywall.st","summary":"Institutional investors are ImmuPharma plc's (LON:IMM) biggest bettors and were rewarded after last week's UK£48m market cap gain - simplywall.st","headline":"Institutional investors are ImmuPharma plc's (LON:IMM) biggest bettors and were rewarded after last week's UK£48m market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNM3RFc2UtTDJmX2VwMGJSZW91NmNPSFJMQWVwa2NkSHdyY1pNdThjcnEwelFTMHo5QnkwVkVCcFBQRC1nbDRpNG1TRVRmTlBtYkdVT2VGc0l0Vk81VHVXWUFDOTFvdTZwOGhqWkNfWUxkcjZweGFENXRrR2laTWZMU01DMUQzeTdtRmlUWFgwaU5aNFlPWVRqbnJGMVU0UUdf?oc=5","date":"2025-09-12","type":"pipeline","source":"Share Talk","summary":"Tim McCarthy, Chief Executive Officer of ImmuPharma PLC talks to Zak Mir - Share Talk","headline":"Tim McCarthy, Chief Executive Officer of ImmuPharma PLC talks to Zak Mir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSkZzUGduNGZYR0ZwWE9sNFJUUGg3Q1NENm9uZ2YzMkMtVkZsMVNEeHlnWE1YZHdGN1BkRE8xT1d6SWxlNHhlamFZbzRwdDlGdzVVM2djaHhHRDV6Mkhwek93alRDZk04WlhxMmNXcWpJbmFocDJrUExwUGFRbDYycnV1NXBYa0NUd0g1ck5mTzR4T0s1V1hmSTVUWThWQVZ1dHFQd2I2bHVEZDlmMnVGVnNKR19DTEtY?oc=5","date":"2025-09-02","type":"patent","source":"Research Tree","summary":"ImmuPharma CEO & CSO on major patent milestone for P140 autoimmune therapy - Research Tree","headline":"ImmuPharma CEO & CSO on major patent milestone for P140 autoimmune therapy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}